IceCure Medical Gets Nasdaq Minimum Bid Price Warning
Ticker: ICCM · Form: 6-K · Filed: Nov 14, 2025 · CIK: 1584371
Sentiment: neutral
Topics: listing-compliance, nasdaq, notification
Related Tickers: ICCM
TL;DR
Nasdaq says IceCure's stock price is too low, needs to fix it or get booted.
AI Summary
On November 14, 2025, IceCure Medical Ltd. announced it received a notification from Nasdaq regarding its minimum bid price requirement. The company is required to regain compliance with the $1.00 minimum bid price per share rule to remain listed on the Nasdaq Capital Market.
Why It Matters
Failure to regain compliance could lead to delisting from the Nasdaq, impacting the company's liquidity and investor confidence.
Risk Assessment
Risk Level: medium — The company faces delisting risk if it cannot meet Nasdaq's minimum bid price requirement.
Key Numbers
- $1.00 — Minimum Bid Price (The minimum price per share required by Nasdaq for continued listing.)
Key Players & Entities
- IceCure Medical Ltd. (company) — Filer of the report
- Nasdaq (company) — Exchange where the company is listed
- November 14, 2025 (date) — Date of the press release and filing
FAQ
What is the specific reason for the Nasdaq notification?
IceCure Medical Ltd. received the notification because its stock has not met the minimum bid price requirement of $1.00 per share.
What is the deadline for IceCure Medical Ltd. to regain compliance?
The filing does not specify a deadline, but Nasdaq typically provides a compliance period.
What are the potential consequences if IceCure Medical Ltd. fails to comply?
Failure to regain compliance could result in the delisting of the company's securities from the Nasdaq Capital Market.
What action has IceCure Medical Ltd. taken in response to this notification?
The company issued a press release on November 14, 2025, titled 'IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification'.
Is this a new development for IceCure Medical Ltd. regarding Nasdaq listing rules?
Yes, this is a specific notification received in November 2025 regarding the minimum bid price rule.
Filing Stats: 291 words · 1 min read · ~1 pages · Grade level 11.5 · Accepted 2025-11-14 17:00:01
Filing Documents
- ea0265494-6k_icecure.htm (6-K) — 11KB
- ea026549401ex99-1_icecure.htm (EX-99.1) — 9KB
- 0001213900-25-111008.txt ( ) — 21KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ICECURE MEDICAL LTD. Date: November 14, 2025 By: /s/ Eyal Shamir Name: Eyal Shamir Title: Chief Executive Officer 2